PharmaGap Inc. (GAP) Announces Successful Completion of Liposomal Development With Significantly Improved Potency of Cancer Drug
9/12/2011 6:57:04 AM
More...
|
PharmaGap Inc. (GAP) Completes Initial Close of Private Placement
7/13/2011 7:11:33 AM
More...
|
PharmaGap Inc. (GAP) Lead Drug to Be Presented at American Association for Cancer Research 102nd Annual Meeting
2/11/2011 9:39:53 AM
More...
|
PharmaGap Inc. (GAP) Provides Clinical Development Program Update
1/27/2011 8:52:19 AM
More...
|
PharmaGap Inc. (GAP) Reports Early Results in Bladder Cancer; Announces Collaboration With Queen’s University to Pursue Development for Clinical Use
12/21/2010 9:36:57 AM
More...
|
PharmaGap Inc. (GAP) Completes Private Placement of Equity Units
11/19/2010 12:55:11 PM
More...
|
PharmaGap Inc. (GAP) Completes Conversion of NRC Debt to Shares
11/4/2010 8:33:50 AM
More...
|
PharmaGap Inc. (GAP) Announces Successful Result From Toxicity Phase Of Latest Testing
10/21/2010 11:07:16 AM
More...
|
PharmaGap Inc. (GAP) Announces Successful Result From Toxicity Phase Of Latest Testing
10/14/2010 8:47:55 AM
More...
|
PharmaGap Inc. (GAP) Provides Guidance on Clinical Drug Development Program for Q4 2010
10/5/2010 9:16:01 AM
More...
|
|